SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000929638-17-000026
Filing Date
2017-01-06
Accepted
2017-01-06 17:04:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 schedule13da.htm SC 13D/A 36631
  Complete submission text file 0000929638-17-000026.txt   38123
Mailing Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 91 HARTWELL AVE 2ND FLOOR LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Subject) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88750 | Film No.: 17514959
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 DEVON PARK DRIVE BUILDING 700 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE BUILDING 700 WAYNE PA 19087 6109777532
DEVON PARK BIOVENTURES LP (Filed by) CIK: 0001356034 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA
Type: SC 13D/A